Results 31 to 40 of about 27,191 (241)

Thalidomide treatment in a myelofibrosis patient with leukemia transformation

, 2017
Primary myelofibrosis is a clonal disease of chronic myeloproliferative neoplasm, and is a progressive clinical course with short median survival of less than 5 years after diagnosis.
Huang, Wei-Han;Li, Ming-Shing;Chu, Sung-Chao;Wang, Tso-Fu;Kao, Ruey-Ho;Wu, Yi-Feng
core   +1 more source

Isolated Subcarinal Lymph Node Recurrence 24 Years After Treatment for Primary Tracheal Adenoid Cystic Carcinoma. [PDF]

Respirol Case Rep
We report a case of isolated subcarinal lymph node recurrence 24 years after treatment for primary tracheal adenoid cystic carcinoma, which required differentiation from haematologic disease‐related conditions after haematopoietic stem cell transplantation for myelofibrosis.
Suzuki Y, Ikushima H, Yamamoto M, Ueki Y, Shinozaki-Ushiku A, Kawakami M, Mitani A, Masamoto Y, Kage H.   +8 more
europepmc   +2 more sources

The human myeloproliferative disorders: molecular pathogenesis and clonal heterogeneity

, 2010
The classical myeloproliferative disorders (MPD), comprising essential thrombocythaemia (ET), polycythaemia vera (PV) and idiopathic myelofibrosis (IMF), are clonal premalignant haematopoietic neoplasms associated with activating mutations in signalling ...

core   +1 more source

Myelofibrosis patients in Belgium : disease characteristics [PDF]

, 2014
Objective: To date, only a small number of epidemiological studies on myelofibrosis have been performed. The current study aimed to characterize the myelofibrosis patient population in Belgium according to predefined disease parameters (diagnosis, risk ...
Devos, Thibaut, Pierre, Pascal, Pierre, P., Zachee, P., Trullemans, F, Berneman, Zwi Nisan, Bron, D., Lemmens, Jan, Van Droogenbroeck, Jan, Van Droogenbroeck, J, Beguin, Y, Devos, T., Van Eygen, K., Mineur, Philippe, Bron, D, Pierre, P, Berneman, Zwi, Benghiat, FS, Chatelain, Christian, Pluymers, Wim, Demuynck, H., Benghiat, F. S., Chatelain, C, Van Eygen, K, Theunissen, Koen, Pluymers, W, Droogenbroeck, Jan Van, Beguin, Yves, Zachée, Pierre, Lemmens, J, Zachée, P, Devos, Timothy, Kentos, A, Berneman, Z, Lemmens, J., Demuynck, H, Trullemans, Fabienne, Benghiat, Fleur, Pluymers, W., Kentos, A., Kentos, Alain, Beguin, Y., Mineur, P, Noens, L., Noens, Lucien, Knoops, L., Knoops, L, Bermeman, Zwi Nisan, Van Droogenbroeck, J., Benghiat, Fleur S, Bron, Domonique, Trullemans, F., Van Eygen, Koen, Mineur, P., Benghiat, Fleur Samantha, Bron, Dominique, Demuynck, Hilde, Chatelain, C., Theunissen, K, Theunissen, K., Devos, T, Theunidden, Koen, Knoops, Laurent, Eygen, Koen Van, Eygen, Koen V   +64 more
core   +1 more source

Case Report: Hematologic Recovery Following Stereotactic Ablative Radiotherapy in a Patient With Early-Stage Non-Small Cell Lung Cancer and Paraneoplastic Myelofibrosis

Frontiers in Oncology, 2022
Herein, we report the first case presentation of paraneoplastic myelofibrosis associated with cancer. Paraneoplastic syndromes occur in some patients with thoracic malignancies; however, myelofibrosis is not commonly seen in non-small cell lung cancer ...
Lindsey Sloan, Lindsey Sloan, Rakhi P. Naik, Kavita Umrau, Rena Ruiyu Xian, Kristen A. Marrone, Khinh Ranh Voong   +6 more
doaj   +1 more source

Understanding the link between PMN-MDSCs and CXCL8-CXCR1/2 axis in primary myelofibrosis

Frontiers in Cell and Developmental Biology
Emergency myelopoiesis in cancer and chronic inflammation leads to the accumulation of myeloid-derived suppressor cells (MDSCs) which localize at tumor sites or areas of chronic inflammation, serving as suppressor cells.
Rita Campanelli, Stefania Mantovani, Christian Ramirez, Toma Tebaldi, Toma Tebaldi, Alessia La Gaipa, Claudia Del Fante, Carlotta Abbà, Adriana Carolei, Paolo Catarsi, Giovanni Barosi, Margherita Massa, Vittorio Rosti   +12 more
doaj   +1 more source

Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome

American Journal of Hematology, EarlyView.
ABSTRACT Acquired von Willebrand Syndrome (AVWS) is a rare bleeding disorder characterized by quantitative or qualitative defects of von Willebrand factor (VWF) in patients without a personal or family history of bleeding. It is frequently associated with systemic diseases, particularly lymphoproliferative disorders (LPDs) and myeloproliferative ...
Alessandro Ciavarella, Luciano Baronciani, Omid Seidizadeh, Paola Colpani, Elio Ingenito, Daniele Cattaneo, Maria Teresa Pagliari, Addolorata Truma, Alessandra Iurlo, Simona Maria Siboni, Flora Peyvandi   +10 more
wiley   +1 more source

Urticarial vasculitis coexisting with primary myelofibrosis – a case report

, 2017
Introduction . Urticarial vasculitis is a subtype of cutaneous leukocytoclastic vasculitis. The disease often accompanies systemic disorders, including hematologic malignancies, connective tissue diseases, and infectious diseases, or may be drug-induced.
Adam Reich, Radomir Reszke
core   +1 more source

A case of mistaken identity: When lupus masquerades as primary myelofibrosis

SAGE Open Medical Case Reports, 2013
Introduction: Autoimmune myelofibrosis is an uncommon hematologic disease characterized by anemia, bone marrow myelofibrosis, and an autoimmune feature. Myelofibrosis is often associated with other conditions, including infections, nutritional/endocrine ...
Edy Hasrouni, Heesun J Rogers, Ali Tabarroki, Valeria Visconte, Fabiola Traina, Manuel Afable, Mikkael A Sekeres, Jaroslaw P Maciejewski, Ramon V Tiu   +8 more
doaj   +1 more source

Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up

Haematologica, 2014
Thrombopoietin-receptor agonists increase platelet counts by stimulating the thrombopoietin receptor. Bone marrow fibrosis has been reported in patients receiving thrombopoietin-receptor agonists.
Waleed Ghanima, Julia Turbiner Geyer, Christina S. Lee, Leonardo Boiocchi, Allison A. Imahiyerobo, Attilio Orazi, James B. Bussel   +6 more
doaj   +1 more source